Georg Breier. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Adrenergic beta-Antagonists/therapeutic useAngiogenesis Inhibitors/therapeutic useAnimalsEndothelium, Vascular/drug effectsHumansNeovascularization, Pathologic/drug therapyPropranolol/therapeutic useTelangiectasia, Hereditary Hemorrhagic/drug therapy
Substances: See more » Adrenergic beta-AntagonistsAngiogenesis InhibitorsPropranolol
Year: 2012 PMID: 22628061 DOI: 10.1160/TH12-05-0312
Source DB: PubMed Journal: Thromb Haemost ISSN: 0340-6245 Impact factor: 5.249